Mechanistically, hepatic Rab2A inhibition protected mice from high-fat diet–induced obesity and was associated with markedly elevated circulating FGF21, the phenotype largely rescued by adenovirus-mediated knockdown of either CREBH or APOB. The gene discussed is RAB2A; the disease is obesity disorder.